{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F36007ba2-864c-4088-8bf8-3e61877756d1","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Year in Review \u2014 Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oncology: Melanoma and Nonmelanoma Skin Cancers Edition\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/36007ba2-864c-4088-8bf8-3e61877756d1\"></iframe>","title":"Year in Review \u2014 Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oncology: Melanoma and Nonmelanoma Skin Cancers Edition","description":"Featuring a discussion on the most impactful updates from 2022 in the management of melanoma and nonmelanoma skin cancers with Dr Omid Hamid and Dr Evan J Lipson, moderated by Dr Neil Love.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/42a4626b-0d3a-4631-b031-0bff74d1dd00/OcY7KwYWJLtNlhTHFFLhe-0W.png"}